An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone in a German user group posted a question about whether the new Mounjaro (tirzepatide) pens they’re about to pick up still include the “golden dose” at the end of the cartridge. They said they buy pens through their family doctor and pay out of pocket, and asked others to report the milligram strength they got and where they bought it. It’s basically a community checking whether recent batches still give that extra little dose people sometimes get. Tirzepatide (brand name Mounjaro) is a prescription injectable drug used to treat type 2 diabetes and, at higher doses, for weight loss in some places. It’s a manufactured molecule that mimics certain gut hormones that help control blood sugar and appetite. The medication comes in prefilled pens with a set total amount of drug in each cartridge; you dial a number of units or milligrams and inject. People who use these pens carefully notice how much drug is left at the very end of the cartridge after the official number of doses. What this thread is describing is a practical, real-world detail users track: sometimes when you finish a pen there’s a small extra amount of medicine left that can be drawn for an additional partial dose — colloquially called a “golden dose.” The post is asking others whether their recent pens still have that leftover volume, and what strength pens they bought (for example, 10 mg pens used as 5 mg per injection). This is anecdotal crowd-sourcing. It’s not controlled data — it’s users sharing personal experiences across different pharmacies and batches — so it tells you about variability people are seeing, not about any official change to the product. Why people care: the leftover liquid can be worth a partial extra injection, which matters when you’re paying out of pocket or trying to stretch supply. For people on a tight budget or in places where access is limited, that little bit of extra drug can reduce costs or delay the next prescription. It also matters for dosing consistency: if different pens give different leftover amounts, users who split doses or count on exact amounts can get uncertain results. Important caveats: this is a user conversation, not a manufacturer announcement. The amount left in a pen can vary with how the pen is manufactured, how it’s used, and whether instructions for prime/flush are followed. Never mix or combine leftover contents from multiple pens unless your prescriber or pharmacist explicitly tells you it’s safe and legal in your country. And don’t try to manipulate pens to get extra doses in ways the manufacturer warns against — that can affect sterility, dose accuracy, and safety. If you depend on Mounjaro for medical reasons, talk to your prescribing doctor or pharmacist about dosing, cost-saving options, and whether pen sharing or extracting extra doses is advisable. Bottom line: people in Germany are swapping reports about whether recent Mounjaro pens still leave a small extra dose at the end — useful practical info but purely anecdotal, so check with a pharmacist or doctor before acting on it.
Source: r/Mounjaro